Healthcare | March 23, 2023
OPPI launches ‘Bharat Ke Liye’ to reinforce commitment to improve health outcomes
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
The summit also saw the launch of two important reports- Multi-Regional Clinical Trials (MRCT) and Value of OTC in India
Machine learning approach to systems biology combined with ligand discovery platform
The awards will be conferred to the winners at the annual summit of OPPI, scheduled on March 23-24
The FDA also noted that current prescribing information for GLP-1 RAs already includes warnings about the risk of suicidal thoughts
The approval follows robust data from the SWIFT and ANCHOR Phase III trials
Elanco expects Befrena to launch in the US in the first half of 2026
Once finalized, cough syrups will no longer be available for over-the-counter sale
For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows
The approval makes AQVESME the only FDA-approved therapy for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia
Subscribe To Our Newsletter & Stay Updated
